![Dan Becker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dan Becker
Directeur/Membre du Conseil chez
ZURA BIO LIMITED
Fortune : - $ au 31/05/2026
Profil
Dan Becker is currently Director at Perfuse Therapeutics, Inc. since 2020, Independent Director at Zura Bio Ltd. starting 2025, Director at Areteia Therapeutics, Inc. since 2024, Managing Director at Access Biotechnology (Venture Capital) since 2019, Director at DOT Therapeutics-2, Inc., Director at Hemab ApS since 2023, Director at Matchpoint Therapeutics, Inc. since 2021, and Principal at Access Industries LLC since 2019.
Former roles include Independent Director at Day One Biopharmaceuticals, Inc. from 2019 to 2024, Independent Director at ACELYRIN, Inc. from 2022 to 2025, Independent Director at Principia Biopharma, Inc. from 2017 to 2020, Director at DTx Pharma, Inc. from 2021 to 2023, Director at Mariana Oncology, Inc. from 2021 to 2024, Independent Non-Executive Director at Pandion Therapeutics, Inc. from 2020 to 2021, Principal at The Boston Consulting Group, Inc. from 2009 to 2015, and Principal at New Leaf Venture Partners LLC from 2015 to 2019.
Education includes a doctorate from the University of Michigan, graduate and doctorate degrees from the University of Michigan Medical School, and an undergraduate degree from the University of Illinois At Urbana–Champaign.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Dan Becker
| Sociétés | Poste | Début |
|---|---|---|
| ZURA BIO LIMITED | Directeur/Membre du Conseil | 21/05/2025 |
Areteia Therapeutics, Inc.
 Areteia Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Directeur/Membre du Conseil | 01/02/2024 |
Hemab ApS
 Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Directeur/Membre du Conseil | 01/02/2023 |
Matchpoint Therapeutics, Inc.
 Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company harnessing the power of covalency to discover precision covalent medicines | Directeur/Membre du Conseil | 01/04/2021 |
Access Industries LLC
 Access Industries LLC Provides advancement of mobility technology | Corporate Officer/Principal | 01/08/2019 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Directeur/Membre du Conseil | - |
Access Biotechnology (Venture Capital)
 Access Biotechnology (Venture Capital) Investment ManagersFinance Access Biotechnology invests in both private and public companies located in the United States. The firm targets companies operating in the field of the biopharma companies. It provides financing for later stage transactions. | Private Equity Investor | 01/08/2019 |
Perfuse Therapeutics, Inc.
 Perfuse Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | 01/07/2020 |
Anciens postes connus de Dan Becker
| Sociétés | Poste | Fin |
|---|---|---|
| ACELYRIN, INC. | Directeur/Membre du Conseil | 21/05/2025 |
| ░░░ ░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Dan Becker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Access Industries LLC
Access Industries LLC Provides advancement of mobility technology | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
University of Michigan Medical School
 University of Michigan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DTx Pharma, Inc.
 DTx Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops siRNA therapies for neuroscience indications | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perfuse Therapeutics, Inc.
Perfuse Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Access Biotechnology (Venture Capital)
Access Biotechnology (Venture Capital) Investment ManagersFinance Access Biotechnology invests in both private and public companies located in the United States. The firm targets companies operating in the field of the biopharma companies. It provides financing for later stage transactions. | Finance |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel therapeutics for autoimmune diseases | Health Technology |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Hemab ApS
Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Areteia Therapeutics, Inc.
Areteia Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Matchpoint Therapeutics, Inc.
Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company harnessing the power of covalency to discover precision covalent medicines | Health Technology |
